← Leaderboards
John Hsu
Kaiser Foundation Research Institute
$21,513,960
Attributed
$26,228,529
Total exposure
15
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.5M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$38,345,715 · 12
AHRQ$896,247 · 4
By mechanism
R01$18,792,540 · 10
P50$13,836,058 · 4
U01$4,115,749 · 1
RF1$2,497,615 · 1
Top collaborators
- Miguel Hernan16 shared
- Dost Ongur15 shared
- Sonia Hernandez-Diaz5 shared
- Sharon-Lise T Normand1 shared
Most similar at Kaiser Foundation Research Institute
Same institution · by research overlap
- Richard W Grant$15,968,167
- Cynthia I Campbell$8,122,939
- Deborah E. Barnes$8,708,473
- Mark Christopher Hornbrook$5,605,661
- James William Dearing$6,344,943
Others in their field
Top investigators on “Caring”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$305,871,236
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$279,179,778
- Chanza Baytop · Westat, Inc.$271,217,917
- Larry Arthur$256,720,406
Research focus
CaringEventBaseFuturePoliciesData SetHospitalizationMedicalCostResourcesDesignMassachusettsClinicModernizationVariantEconomicsNatural ExperimentSourcePatternStructureAlzheimer&AposHealth SystemDiagnosisLiterature
Grant awards (57)
Laboratory for Early Psychosis Research (LEAP)$1,969,525
P50 · FY2025 · MH
Impact of Care Delivery and Therapeutic Changes on Patients with Alzheimer's Disease and Alzheimer's Disease Related Dementias$789,438
U01 · FY2025 · AG · contact PI
Laboratory for Early Psychosis Research (LEAP)$2,037,513
P50 · FY2024 · MH
Impact of the COVID-19 Pandemic on Patients with Alzheimer's Disease and Alzheimer's Disease Related Dementias$814,164
U01 · FY2024 · AG · contact PI
Impact of Medicare Polices on Beneficiaries with ADRD$2,497,615
RF1 · FY2023 · AG · contact PI
Laboratory for Early Psychosis Research (LEAP)$2,138,706
P50 · FY2023 · MH
Impact of the COVID-19 Pandemic on Patients with Alzheimer's Disease and Alzheimer's Disease Related Dementias$822,779
U01 · FY2023 · AG · contact PI
Laboratory for Early Psychosis Research (LEAP)$1,634,573
P50 · FY2022 · MH
Impact of the COVID-19 Pandemic on Patients with Alzheimer's Disease and Alzheimer's Disease Related Dementias$831,392
U01 · FY2022 · AG · contact PI
Alzheimer's Disease and Related Dementia Care within the Medicare Program$815,120
R01 · FY2022 · AG · contact PI
Long-term Impact of Fertility Treatment Study$540,673
R01 · FY2022 · HD · contact PI
Laboratory for Early Psychosis Research (LEAP)$100,000
P50 · FY2022 · MH
Laboratory for Early Psychosis Research (LEAP)$1,640,084
P50 · FY2021 · MH
Impact of the COVID-19 Pandemic on Patients with Alzheimer's Disease and Alzheimer's Disease Related Dementias$857,976
U01 · FY2021 · AG · contact PI
Alzheimer's Disease and Related Dementia Care within the Medicare Program$703,891
R01 · FY2021 · AG · contact PI
Long-term Impact of Fertility Treatment Study$541,816
R01 · FY2021 · HD · contact PI
Examining Pathways to Care$304,096
P50 · FY2021 · MH · contact PI
Laboratory for Early Psychosis Research (LEAP)$1,704,908
P50 · FY2020 · MH
Alzheimer's Disease and Related Dementia Care within the Medicare Program$710,631
R01 · FY2020 · AG · contact PI
COVID-19 and Acute Medical Care: Impact on Dementia Patients$654,203
R01 · FY2020 · AG · contact PI
Long-term Impact of Fertility Treatment Study$552,873
R01 · FY2020 · HD · contact PI
Examining Pathways to Care$237,050
P50 · FY2020 · MH · contact PI
ConProject-004$44,797
P50 · FY2020 · MH
ConProject-003$23,584
P50 · FY2020 · MH
Laboratory for Early Psychosis Research (LEAP)$1,467,963
P50 · FY2019 · MH
Alzheimer's Disease and Related Dementia Care within the Medicare Program$815,091
R01 · FY2019 · AG · contact PI
Laboratory for Early Psychosis Research (LEAP)$320,161
P50 · FY2019 · MH
Examining Pathways to Care$213,098
P50 · FY2019 · MH · contact PI
Alzheimer's Disease and Related Dementia Care within the Medicare Program$849,724
R01 · FY2018 · AG · contact PI
Long-term Impact of Fertility Treatment Study$563,241
R01 · FY2018 · HD · contact PI
Long-term Impact of Fertility Treatment Study$665,167
R01 · FY2017 · HD · contact PI
Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients$427,607
R01 · FY2017 · MH
Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients$968,613
R01 · FY2016 · MH
Natural Experiment of Value-Based Incentives for Preventive Services$659,932
R01 · FY2016 · HD · contact PI
Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients$968,554
R01 · FY2015 · MH
Natural Experiment of Value-Based Incentives for Preventive Services$659,932
R01 · FY2015 · HD · contact PI
Screening for Free: A Value-Based Insurance Design Natural Experiment$574,154
R01 · FY2015 · CA · contact PI
Natural Experiment of Value-Based Incentives for Preventive Services$659,932
R01 · FY2014 · HD · contact PI
Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients$657,215
R01 · FY2014 · MH
Screening for Free: A Value-Based Insurance Design Natural Experiment$556,577
R01 · FY2014 · CA · contact PI
To Screen or Not To Screen: Prevention Decisions and Competing Risks$398,953
R01 · FY2014 · HS · contact PI
Natural Experiment of Value-Based Incentives for Preventive Services$644,636
R01 · FY2013 · HD · contact PI
Screening for Free: A Value-Based Insurance Design Natural Experiment$560,414
R01 · FY2013 · CA · contact PI
Natural Experiment of Value-Based Incentives for Preventive Services$709,623
R01 · FY2012 · HD · contact PI
Screening for Free: A Value-Based Insurance Design Natural Experiment$663,309
R01 · FY2012 · CA · contact PI
Medicare Study of Cost-sharing Ramifications and Prescription Drug Benefits$433,900
R01 · FY2009 · AG · contact PI
Medicare Study of Cost-sharing Ramifications and Prescription Drug Benefits$154,893
R01 · FY2009 · AG · contact PI
Medicare Study of Cost-sharing Ramifications and Prescription Drug Benefits$588,343
R01 · FY2008 · AG · contact PI
Medicare Study of Cost-sharing Ramifications and Prescription Drug Benefits$596,229
R01 · FY2007 · AG · contact PI
Impact of Health Information Technology on Clinical Care$497,294
R01 · FY2006 · HS · contact PI
Impact of Health Information Technology on Clinical Care$0
R01 · FY2005 · HS
Prescription Drug Cost-sharing: Affordability/Safety$0
R01 · FY2005 · HS
Prescription Drug Cost-sharing: Affordability/Safety$0
R01 · FY2004 · HS
Impact of Health Information Technology on Clinical Care$0
R01 · FY2004 · HS
Prescription Drug Cost-sharing: Affordability/Safety$0
R01 · FY2003 · HS
Safety And Financial Ramifications of ED Copayments$0
R01 · FY2002 · HS
Safety And Financial Ramifications of ED Copayments$0
R01 · FY2001 · HS